Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:293-294

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heistad, D. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Heistad, D. D.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:293.)
© 2001 American Heart Association, Inc.


Editorial

A Progress Report

Donald D. Heistad, Editor-in-Chief,; for the Editors
This issue marks the end of the second year of our editorship, which began in March of 1999. We wish to summarize some changes in the Journal and to thank several groups of people for their help. We will summarize changes in relation to several goals of the Editors: to publish high-quality articles, provide timely review and publication, and publish articles that are of interest to our readers. We will then describe the effects on Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) of the electronic revolution in medical publishing.

Publication of High-Quality Articles

Selection of manuscripts for publication depends in part on scientific validity of findings, as perceived by reviewers, the Editorial Board, and the Editors. Also of great importance is our perception of the likely impact of articles: will the study influence the area of research?

Evaluation of quality of articles in a Journal is exceedingly difficult. One approach is calculation of "impact factor." The latest available data (for 1999) indicate that the impact of the articles in ATVB increased almost 40% during 1999 (Figure 1Down). Compared with some other journals that publish articles related to atherosclerosis and lipoproteins, vascular biology, and thrombosis (Figure 1Down), the Journal is doing very well. Some other journals in this area of research, however, have a higher impact factor (Figure 2Down), and ATVB has not yet achieved that level. Nevertheless, the recent 40% increase in impact factor is remarkable.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Impact factor for Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB), Thrombosis and Haemostasis (Throm), Journal of Lipid . . . [Full Text of this Article]